pharma · Breast Cancer · Breastcancer · BCTX
BriaCell Therapeutics
BriaCell Therapeutics drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Philadelphia, USA HQ
2004 Founded
24 Employees
Public company Type
BCTX · NYSE Ticker
Company details
- Status
- Public
- HQ
- Philadelphia, USA
- Founded
- 2004
- Employees
- 24
- Programs
- 3
- Drugs
- 0
- Patents
- 1
BriaCell Therapeutics pipeline
Portfolio lens on 0 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
BriaCell Therapeutics drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.